- Home
- LOVE vs RCKT Comparison
LOVE vs RCKT Comparison
Compare LOVE & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOVE | RCKT |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.4M | 239.3M |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LOVE | RCKT |
|---|---|---|
| Price | $14.36 | $2.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 14 |
| Target Price | ★ $23.17 | $8.58 |
| AVG Volume (30 Days) | 198.0K | ★ 2.2M |
| Earning Date | 09-10-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.37 |
| EPS | N/A | ★ 0.66 |
| Revenue | ★ $697,115,000.00 | N/A |
| Revenue This Year | $0.13 | N/A |
| Revenue Next Year | $7.96 | $915.60 |
| P/E Ratio | ★ N/A | $3.29 |
| Revenue Growth | ★ 2.42 | N/A |
| 52 Week Low | $10.33 | $2.17 |
| 52 Week High | $19.25 | $5.45 |
Technical Indicators
Market Signals| Indicator | LOVE | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 44.98 | 32.30 |
| Support Level | $13.43 | N/A |
| Resistance Level | $16.13 | $3.70 |
| Average True Range (ATR) | 0.58 | 0.16 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 19.43 | 11.38 |
Price Performance
Historical ComparisonAbout LOVE The Lovesac Company
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.